PATENT CLAIM ANALYSIS

Application Number: 16124497
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["514", "255030"]

Abstract:
The invention provides new therapeutic uses of 1-[2-(2,4-dimethyl-phenylsulfanyl)phenyl]-piperazine and pharmaceutically acceptable salts thereof.

Claim (Index 5):
1-[2-(2,4-dimethyl-phenylsulfanyl)phenyl]piperazine and pharmaceutically acceptable salts thereof for use in the treatment of a CNS disease in a patient who also suffers from a disease where weight increase should be avoided.

Metadata:
- Claim Count in Document: 35.0
- Percentile: 97.0
- Lexical Diversity: 1.0
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['12741780', '15043167', '15315182', '14767350', '14649087']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7572664010049731
- 35 USC 102 Novelty (BERT): 0.4976033366520309
- Combined Prediction Score: 0.7313000945696788
- Mean Citation Score: 211.074214
- Max Citation Score: 229.31255
- Similarity Product: 164.32166947359443

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test